Chemed (NYSE:CHE) Director Patrick Grace Sells 190 Shares

Chemed Corporation (NYSE:CHE) Director Patrick Grace sold 190 shares of Chemed stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the sale, the director owned 3,533 shares in the company, valued at $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Chemed Price Performance

CHE opened at $540.89 on Tuesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $551.68. The firm has a 50-day moving average of $469.13 and a 200 day moving average of $437.15. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The firm has a market cap of $7.18 billion, a P/E ratio of 27.17, a PEG ratio of 2.02 and a beta of 0.51.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same quarter in the prior year, the firm earned $4.27 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is currently 12.05%.

Hedge Funds Weigh In On Chemed

Hedge funds have recently bought and sold shares of the company. Monetary Solutions Ltd purchased a new stake in Chemed in the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC purchased a new position in shares of Chemed during the 4th quarter valued at $26,000. BOK Financial Private Wealth Inc. bought a new position in shares of Chemed in the fourth quarter worth $27,000. Versant Capital Management Inc increased its holdings in shares of Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after purchasing an additional 75 shares during the period. Finally, MassMutual Private Wealth & Trust FSB raised its position in shares of Chemed by 65.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after buying an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on CHE shares. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Bank of America restated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Oppenheimer raised their price target on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Chemed has a consensus rating of “Hold” and an average price target of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.